Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

JAK inhibitors are effective treatments for alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Janus kinase inhibitors may help treat lichen planopilaris.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

JAK inhibitors may help improve symptoms in adults with APECED.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

A patient's gum problems worsened after using cyclosporine for a scalp condition, but improved with a lower dose.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.